Showing 1 - 7 results of 7 for search 'Erden Banoglu', query time: 0.03s Refine Results
  1. 1
    1-(4-klorofenil)-3-metil-5-{4-[(2-metilfenil)metoksi]fenil}-1H-pirazol’ün Kristal Yapısı ve Hirshfeld Yüzey Analizi

    1-(4-klorofenil)-3-metil-5-{4-[(2-metilfenil)metoksi]fenil}-1H-pirazol’ün Kristal Yapısı ve Hirshfeld Yüzey Analizi by Sumeyye Turanlı, Mehmet Akkurt, Erden Banoğlu, Nefise Özçelik, Abdullah Aydın

    Published 2022-01-01
    Get full text
    Article
  2. 2
    Optimisation by Design of Experiment of Benzimidazol-2-One Synthesis under Flow Conditions

    Optimisation by Design of Experiment of Benzimidazol-2-One Synthesis under Flow Conditions by Serena Mostarda, Tugçe Gür Maz, Alessandro Piccinno, Bruno Cerra, Erden Banoglu

    Published 2019-07-01
    Get full text
    Article
  3. 3
    Crystal structure and Hirshfeld surface analysis of 4-(4-chlorophenyl)-5-methyl-3-{4-[(2-methylphenyl)methoxy]phenyl}-1,2-oxazole

    Crystal structure and Hirshfeld surface analysis of 4-(4-chlorophenyl)-5-methyl-3-{4-[(2-methylphenyl)methoxy]phenyl}-1,2-oxazole by Abdullah Aydin, Mehmet Akkurt, Sumeyye Turanli, Deniz Lengerli, Erden Banoglu, Nefise Dilek Ozcelik

    Published 2021-04-01
    Get full text
    Article
  4. 4
    Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5‑Lipoxygenase-Activating Protein

    Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5‑Lipoxygenase-Activating Protein by Abdurrahman Olğaç, İrfan Çapan, Philipp Dahlke, Paul M. Jordan, Oliver Werz, Erden Banoglu

    Published 2023-08-01
    Get full text
    Article
  5. 5
    Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents

    Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents by Burcu Çalışkan, Esra Sinoplu, Kübra İbiş, Ece Akhan Güzelcan, Rengül Çetin Atalay, Erden Banoglu

    Published 2018-01-01
    Get full text
    Article
  6. 6
    Correction: Encapsulation of the dual FLAP/mPEGS‑1 inhibitor BRP‑187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity

    Correction: Encapsulation of the dual FLAP/mPEGS‑1 inhibitor BRP‑187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity by Blerina Shkodra, Christian Kretzer, Paul M. Jordan, Paul Klemm, Andreas Koeberle, David Pretzel, Erden Banoglu, Stefan Lorkowski, Maria Wallert, Stephanie Höppener, Steffi Stumpf, Antje Vollrath, Stephanie Schubert, Oliver Werz, Ulrich S. Schubert

    Published 2024-02-01
    Get full text
    Article
  7. 7
    Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity

    Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity by Blerina Shkodra-Pula, Christian Kretzer, Paul M. Jordan, Paul Klemm, Andreas Koeberle, David Pretzel, Erden Banoglu, Stefan Lorkowski, Maria Wallert, Stephanie Höppener, Steffi Stumpf, Antje Vollrath, Stephanie Schubert, Oliver Werz, Ulrich S. Schubert

    Published 2020-05-01
    Get full text
    Article

Search Tools: